News Quantified

DNLI – denali therapeutics inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial [Yahoo! Finance]

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation? [Yahoo! Finance]

BioHive Announces BioHive Live [Yahoo! Finance]

Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at UBS Group AG from $70.00 to $32.00. They now have a "buy" rating on the stock.

21.4%

MISS

-4.9%

BEAT

2.9%

MISS

Form ARS Denali Therapeutics Inc. For: Dec 31

Form DEFA14A Denali Therapeutics Inc.

Form DEF 14A Denali Therapeutics Inc. For: Dec 31

Form 4 Denali Therapeutics Inc. For: Apr 15 Filed by: SATO VICKI L

Form 144 Denali Therapeutics Inc. Filed by: SATO VICKI L

Top News Gainers

1/14 Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease 29.4%

1/26 Denali Therapeutics Inc (NASDAQ: DNLI) was upgraded by analysts at Goldman Sachs Group Inc from a "neutral" rating to a "buy" rating. 13.7%

4/1 Form 4/A Denali Therapeutics Inc. For: Feb 08 Filed by: Watts Ryan J. 8.9%

3/13 Denali Therapeutics Inc (NASDAQ: DNLI) was upgraded by analysts at Evercore ISI to an "outperform" rating. 7.9%

7/2 Denali Therapeutics Inc (NASDAQ: DNLI) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $23.00 price target on the stock. 6.2%

10/21 Denali Therapeutics Inc (NASDAQ: DNLI) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 5.7%

1/30 Goldman Sachs: These 2 Stocks Are Poised to Surge by at Least 35% [Yahoo! Finance News] 5.3%

12/3 30 Under 30 2020: Meet The Sports World’s Brightest Young Stars [Forbes] 4.6%

6/15 Denali Therapeutics Inc (NASDAQ: DNLI) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 4.5%

11/26 Form 4 Denali Therapeutics Inc. For: Nov 22 Filed by: Schuth Alexander O. 4.5%

Top News Decliners

2/26 Denali Therapeutics Inc (NASDAQ: DNLI) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -12.1%

3/30 Denali Therapeutics Inc (NASDAQ: DNLI) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. -11.1%

1/27 Denali Therapeutics Announces Proposed Offering of Common Stock -10.0%

1/15 Denali Therapeutics Inc (NASDAQ: DNLI) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -9.3%

9/25 Denali Therapeutics Inc (NASDAQ: DNLI) is now covered by analysts at Wedbush. They set a "neutral" rating on the stock. -9.1%

2/24 Denali Therapeutics Inc (NASDAQ: DNLI) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating and a $35.00 price target on the stock. -7.2%

5/10 Form 4/A Denali Therapeutics Inc. For: Apr 01 Filed by: Ho Carole -6.7%

1/29 Form 424B5 Denali Therapeutics Inc. -6.5%

3/12 Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer -6.2%

9/13 Denali Therapeutics Inc (NASDAQ: DNLI) is now covered by analysts at Nomura. They set a "buy" rating on the stock. -5.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day